Thyroid Ultrasound Reporting Lexicon: White Paper of the ACR Thyroid Imaging, Reporting and Data System (TIRADS) Committee.
Grant EG, Tessler FN, Hoang JK, Langer JE, Beland MD, Berland LL, Cronan JJ, Desser TS, Frates MC, Hamper UM, Middleton WD, Reading CC, Scoutt LM, Stavros AT, Teefey SA.
J Am Coll Radiol. 2015 Dec;12(12 Pt A):1272-9. doi: 10.1016/j.jacr.2015.07.011. Epub 2015 Sep 26.
Distinct molecular subtypes of papillary thyroid carcinoma and gene signature with diagnostic capability.
Hong S, Xie Y, Cheng Z, Li J, He W, Guo Z, Zhang Q, Peng S, He M, Yu S, Xu L, Liu R, Xu T, Zhang Y, Li Y, Wang J, Lv W, Yu J, Xiao H.
Oncogene. 2022 Nov;41(47):5121-5132. doi: 10.1038/s41388-022-02499-0. Epub 2022 Oct 17.
RAS-positive thyroid nodules.
Angell TE.
Curr Opin Endocrinol Diabetes Obes. 2017 Oct;24(5):372-376. doi: 10.1097/MED.0000000000000354.
Thyroid Nodules and Obesity.
Demetriou E, Fokou M, Frangos S, Papageorgis P, Economides PA, Economides A.
Life (Basel). 2023 May 31;13(6):1292. doi: 10.3390/life13061292.
FAM172A promotes follicular thyroid carcinogenesis and may be a marker of FTC.
Xu PP, Zeng S, Xia XT, Ye ZH, Li MF, Chen MY, Xia T, Xu JJ, Jiao Q, Liu L, Li LX, Guo MG.
Endocr Relat Cancer. 2020 Nov;27(11):657-669. doi: 10.1530/ERC-20-0181.
Oncogenesis of Thyroid Cancer.
Younis E.
Asian Pac J Cancer Prev. 2017 May 1;18(5):1191-1199. doi: 10.22034/APJCP.2017.18.5.1191.
Oncogene-induced cellular senescence.
Chandeck C, Mooi WJ.
Adv Anat Pathol. 2010 Jan;17(1):42-8. doi: 10.1097/PAP.0b013e3181c66f4e.
MIEAP and ATG5 are tumor suppressors in a mouse model of BRAF(V600E)-positive thyroid cancer.
Hamada K, Kurashige T, Shimamura M, Arakawa H, Nakamura Y, Nagayama Y.
Front Endocrinol (Lausanne). 2022 Sep 15;13:932754. doi: 10.3389/fendo.2022.932754. eCollection 2022.
Diagnostic accuracy of thyroid nodule growth to predict malignancy in thyroid nodules with benign cytology: systematic review and meta-analysis.
Singh Ospina N, Maraka S, Espinosa DeYcaza A, O'Keeffe D, Brito JP, Gionfriddo MR, Castro MR, Morris JC, Erwin P, Montori VM.
Clin Endocrinol (Oxf). 2016 Jul;85(1):122-31. doi: 10.1111/cen.12975. Epub 2016 Jan 25.
Urologic conditions associated with malignancy.
Lo EM, Hotaling JM, Pastuszak AW.
Urol Oncol. 2020 Jan;38(1):23-30. doi: 10.1016/j.urolonc.2018.12.018. Epub 2019 Jan 2.
